<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Vaginal Cancer</title>
    <link>http://www.newstin.co.uk/uk/vaginal-cancer</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Vaginal Cancer - News</title>
      <link>http://www.newstin.co.uk/uk/vaginal-cancer</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Sun, 08 Nov 2009 10:45:58 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/vaginal-cancer</guid>
      <dc:date>2009-11-08T10:45:58Z</dc:date>
    </item>
    <item>
      <title>CDC Advisory Committee On Immunization Practices Votes For Permissive Use And For Vaccines For...</title>
      <link />
      <description />
      <pubDate>Fri, 23 Oct 2009 06:08:48 GMT</pubDate>
      <guid />
      <dc:date>2009-10-23T06:08:48Z</dc:date>
    </item>
    <item>
      <title>CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for...</title>
      <link />
      <description />
      <pubDate>Wed, 21 Oct 2009 18:52:00 GMT</pubDate>
      <guid />
      <dc:date>2009-10-21T18:52:00Z</dc:date>
    </item>
    <item>
      <title>FDA Approves GARDASIL® for Use in Boys and Young Men</title>
      <link />
      <description />
      <pubDate>Sat, 17 Oct 2009 01:00:00 GMT</pubDate>
      <guid />
      <dc:date>2009-10-17T01:00:00Z</dc:date>
    </item>
    <item>
      <title>FDA Approves GARDASIL® for Use in Boys and Young Men</title>
      <link />
      <description />
      <pubDate>Fri, 16 Oct 2009 17:22:00 GMT</pubDate>
      <guid />
      <dc:date>2009-10-16T17:22:00Z</dc:date>
    </item>
    <item>
      <title>FDA Approves GARDASIL® For Use In Boys And Young Men</title>
      <link />
      <description />
      <pubDate>Fri, 16 Oct 2009 19:00:10 GMT</pubDate>
      <guid />
      <dc:date>2009-10-16T19:00:10Z</dc:date>
    </item>
    <item>
      <title>Cervical Cancer Surgery in India at Special surgery cells of Mumbai</title>
      <link />
      <description />
      <pubDate>Sat, 10 Oct 2009 10:49:09 GMT</pubDate>
      <guid />
      <dc:date>2009-10-10T10:49:09Z</dc:date>
    </item>
    <item>
      <title>New Independent Study Reinforces Safety Profile of GARDASIL, the Cervical Cancer Vaccine</title>
      <link />
      <description />
      <pubDate>Sun, 27 Sep 2009 10:57:32 GMT</pubDate>
      <guid />
      <dc:date>2009-09-27T10:57:32Z</dc:date>
    </item>
    <item>
      <title>Merck And QIAGEN Collaborate To Accelerate Access To Cervical Cancer Vaccination And Screening In...</title>
      <link />
      <description />
      <pubDate>Thu, 24 Sep 2009 05:32:24 GMT</pubDate>
      <guid />
      <dc:date>2009-09-24T05:32:24Z</dc:date>
    </item>
    <item>
      <title>Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in...</title>
      <link />
      <description />
      <pubDate>Wed, 23 Sep 2009 14:21:43 GMT</pubDate>
      <guid />
      <dc:date>2009-09-23T14:21:43Z</dc:date>
    </item>
  </channel>
</rss>

